Black Diamond Therapeutics, Inc. (BDTX)
Nasdaq: BDTX · CIK 0001701541 · United States
Every official Black Diamond Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open BDTX filings
Black Diamond Therapeutics, Inc. documents
- Black Diamond Therapeutics, Inc. 10-K 2026BDTX 10-K 2026: annual report for fiscal 2026
- Black Diamond Therapeutics, Inc. 10-K 2025BDTX 10-K 2025: annual report for fiscal 2025
- Black Diamond Therapeutics, Inc. 10-K 2024BDTX 10-K 2024: annual report for fiscal 2024
- Black Diamond Therapeutics, Inc. 10-K 2023BDTX 10-K 2023: annual report for fiscal 2023
- Black Diamond Therapeutics, Inc. 10-K 2022BDTX 10-K 2022: annual report for fiscal 2022
- Black Diamond Therapeutics, Inc. 10-Q 2026BDTX 10-Q 2026: quarterly report for fiscal 2026
- Black Diamond Therapeutics, Inc. 10-Q 2025BDTX 10-Q 2025: quarterly report for fiscal 2025
- Black Diamond Therapeutics, Inc. 10-Q 2024BDTX 10-Q 2024: quarterly report for fiscal 2024
- Black Diamond Therapeutics, Inc. 10-Q 2023BDTX 10-Q 2023: quarterly report for fiscal 2023
- Black Diamond Therapeutics, Inc. 10-Q 2022BDTX 10-Q 2022: quarterly report for fiscal 2022
- Black Diamond Therapeutics, Inc. 8-K 2026BDTX 8-K 2026: current report for fiscal 2026
- Black Diamond Therapeutics, Inc. 8-K 2025BDTX 8-K 2025: current report for fiscal 2025
- Black Diamond Therapeutics, Inc. 8-K 2024BDTX 8-K 2024: current report for fiscal 2024
- Black Diamond Therapeutics, Inc. 8-K 2023BDTX 8-K 2023: current report for fiscal 2023
- Black Diamond Therapeutics, Inc. 8-K 2022BDTX 8-K 2022: current report for fiscal 2022
- Black Diamond Therapeutics, Inc. DEF 14A 2026BDTX DEF 14A 2026: proxy statement for fiscal 2026
- Black Diamond Therapeutics, Inc. DEF 14A 2025BDTX DEF 14A 2025: proxy statement for fiscal 2025
- Black Diamond Therapeutics, Inc. DEF 14A 2024BDTX DEF 14A 2024: proxy statement for fiscal 2024
- Black Diamond Therapeutics, Inc. DEF 14A 2023BDTX DEF 14A 2023: proxy statement for fiscal 2023
- Black Diamond Therapeutics, Inc. DEF 14A 2022BDTX DEF 14A 2022: proxy statement for fiscal 2022
- Black Diamond Therapeutics, Inc. Form 4 2026BDTX Form 4 2026: insider trading filing for fiscal 2026
- Black Diamond Therapeutics, Inc. Form 4 2025BDTX Form 4 2025: insider trading filing for fiscal 2025
- Black Diamond Therapeutics, Inc. Form 4 2024BDTX Form 4 2024: insider trading filing for fiscal 2024
- Black Diamond Therapeutics, Inc. Form 4 2023BDTX Form 4 2023: insider trading filing for fiscal 2023
- Black Diamond Therapeutics, Inc. Form 4 2022BDTX Form 4 2022: insider trading filing for fiscal 2022
- Black Diamond Therapeutics, Inc. S-1 2026BDTX S-1 2026: registration statement for fiscal 2026
- Black Diamond Therapeutics, Inc. S-1 2025BDTX S-1 2025: registration statement for fiscal 2025
- Black Diamond Therapeutics, Inc. S-1 2024BDTX S-1 2024: registration statement for fiscal 2024
- Black Diamond Therapeutics, Inc. S-1 2023BDTX S-1 2023: registration statement for fiscal 2023
- Black Diamond Therapeutics, Inc. S-1 2022BDTX S-1 2022: registration statement for fiscal 2022
- Black Diamond Therapeutics, Inc. 13F 2026BDTX 13F 2026: institutional holdings for fiscal 2026
- Black Diamond Therapeutics, Inc. 13F 2025BDTX 13F 2025: institutional holdings for fiscal 2025
- Black Diamond Therapeutics, Inc. 13F 2024BDTX 13F 2024: institutional holdings for fiscal 2024
- Black Diamond Therapeutics, Inc. 13F 2023BDTX 13F 2023: institutional holdings for fiscal 2023
- Black Diamond Therapeutics, Inc. 13F 2022BDTX 13F 2022: institutional holdings for fiscal 2022
More companies